Cargando…
P968: ADDITION OF IXAZOMIB TO POMALIDOMIDE AND DEXAMETHASONE IMPROVES PROGRESSION-FREE SURVIVAL FOR MULTIPLE MYELOMA PATIENTS PROGRESSING ON LENALIDOMIDE AS PART OF 1ST LINE THERAPY: ALLIANCE A061202
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429562/ http://dx.doi.org/10.1097/01.HS9.0000846740.75414.50 |
| _version_ | 1784779485810262016 |
|---|---|
| author | Voorhees, P. Suman, V. Efebera, Y. Raje, N. Tuchman, S. Rodriguez, C. Santo, K. Bova-Solem, M. Carlisle, D. Saad, U. McCarthy, P. Richardson, P. |
| author_facet | Voorhees, P. Suman, V. Efebera, Y. Raje, N. Tuchman, S. Rodriguez, C. Santo, K. Bova-Solem, M. Carlisle, D. Saad, U. McCarthy, P. Richardson, P. |
| author_sort | Voorhees, P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429562 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94295622022-08-31 P968: ADDITION OF IXAZOMIB TO POMALIDOMIDE AND DEXAMETHASONE IMPROVES PROGRESSION-FREE SURVIVAL FOR MULTIPLE MYELOMA PATIENTS PROGRESSING ON LENALIDOMIDE AS PART OF 1ST LINE THERAPY: ALLIANCE A061202 Voorhees, P. Suman, V. Efebera, Y. Raje, N. Tuchman, S. Rodriguez, C. Santo, K. Bova-Solem, M. Carlisle, D. Saad, U. McCarthy, P. Richardson, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429562/ http://dx.doi.org/10.1097/01.HS9.0000846740.75414.50 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Voorhees, P. Suman, V. Efebera, Y. Raje, N. Tuchman, S. Rodriguez, C. Santo, K. Bova-Solem, M. Carlisle, D. Saad, U. McCarthy, P. Richardson, P. P968: ADDITION OF IXAZOMIB TO POMALIDOMIDE AND DEXAMETHASONE IMPROVES PROGRESSION-FREE SURVIVAL FOR MULTIPLE MYELOMA PATIENTS PROGRESSING ON LENALIDOMIDE AS PART OF 1ST LINE THERAPY: ALLIANCE A061202 |
| title | P968: ADDITION OF IXAZOMIB TO POMALIDOMIDE AND DEXAMETHASONE IMPROVES PROGRESSION-FREE SURVIVAL FOR MULTIPLE MYELOMA PATIENTS PROGRESSING ON LENALIDOMIDE AS PART OF 1ST LINE THERAPY: ALLIANCE A061202 |
| title_full | P968: ADDITION OF IXAZOMIB TO POMALIDOMIDE AND DEXAMETHASONE IMPROVES PROGRESSION-FREE SURVIVAL FOR MULTIPLE MYELOMA PATIENTS PROGRESSING ON LENALIDOMIDE AS PART OF 1ST LINE THERAPY: ALLIANCE A061202 |
| title_fullStr | P968: ADDITION OF IXAZOMIB TO POMALIDOMIDE AND DEXAMETHASONE IMPROVES PROGRESSION-FREE SURVIVAL FOR MULTIPLE MYELOMA PATIENTS PROGRESSING ON LENALIDOMIDE AS PART OF 1ST LINE THERAPY: ALLIANCE A061202 |
| title_full_unstemmed | P968: ADDITION OF IXAZOMIB TO POMALIDOMIDE AND DEXAMETHASONE IMPROVES PROGRESSION-FREE SURVIVAL FOR MULTIPLE MYELOMA PATIENTS PROGRESSING ON LENALIDOMIDE AS PART OF 1ST LINE THERAPY: ALLIANCE A061202 |
| title_short | P968: ADDITION OF IXAZOMIB TO POMALIDOMIDE AND DEXAMETHASONE IMPROVES PROGRESSION-FREE SURVIVAL FOR MULTIPLE MYELOMA PATIENTS PROGRESSING ON LENALIDOMIDE AS PART OF 1ST LINE THERAPY: ALLIANCE A061202 |
| title_sort | p968: addition of ixazomib to pomalidomide and dexamethasone improves progression-free survival for multiple myeloma patients progressing on lenalidomide as part of 1st line therapy: alliance a061202 |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429562/ http://dx.doi.org/10.1097/01.HS9.0000846740.75414.50 |
| work_keys_str_mv | AT voorheesp p968additionofixazomibtopomalidomideanddexamethasoneimprovesprogressionfreesurvivalformultiplemyelomapatientsprogressingonlenalidomideaspartof1stlinetherapyalliancea061202 AT sumanv p968additionofixazomibtopomalidomideanddexamethasoneimprovesprogressionfreesurvivalformultiplemyelomapatientsprogressingonlenalidomideaspartof1stlinetherapyalliancea061202 AT efeberay p968additionofixazomibtopomalidomideanddexamethasoneimprovesprogressionfreesurvivalformultiplemyelomapatientsprogressingonlenalidomideaspartof1stlinetherapyalliancea061202 AT rajen p968additionofixazomibtopomalidomideanddexamethasoneimprovesprogressionfreesurvivalformultiplemyelomapatientsprogressingonlenalidomideaspartof1stlinetherapyalliancea061202 AT tuchmans p968additionofixazomibtopomalidomideanddexamethasoneimprovesprogressionfreesurvivalformultiplemyelomapatientsprogressingonlenalidomideaspartof1stlinetherapyalliancea061202 AT rodriguezc p968additionofixazomibtopomalidomideanddexamethasoneimprovesprogressionfreesurvivalformultiplemyelomapatientsprogressingonlenalidomideaspartof1stlinetherapyalliancea061202 AT santok p968additionofixazomibtopomalidomideanddexamethasoneimprovesprogressionfreesurvivalformultiplemyelomapatientsprogressingonlenalidomideaspartof1stlinetherapyalliancea061202 AT bovasolemm p968additionofixazomibtopomalidomideanddexamethasoneimprovesprogressionfreesurvivalformultiplemyelomapatientsprogressingonlenalidomideaspartof1stlinetherapyalliancea061202 AT carlisled p968additionofixazomibtopomalidomideanddexamethasoneimprovesprogressionfreesurvivalformultiplemyelomapatientsprogressingonlenalidomideaspartof1stlinetherapyalliancea061202 AT saadu p968additionofixazomibtopomalidomideanddexamethasoneimprovesprogressionfreesurvivalformultiplemyelomapatientsprogressingonlenalidomideaspartof1stlinetherapyalliancea061202 AT mccarthyp p968additionofixazomibtopomalidomideanddexamethasoneimprovesprogressionfreesurvivalformultiplemyelomapatientsprogressingonlenalidomideaspartof1stlinetherapyalliancea061202 AT richardsonp p968additionofixazomibtopomalidomideanddexamethasoneimprovesprogressionfreesurvivalformultiplemyelomapatientsprogressingonlenalidomideaspartof1stlinetherapyalliancea061202 |